Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Druggability Technologies Announces Financial Investment by SPCH

Abstract:
Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000. The round was led by Andrew Midler through his investment entity, SPCH. Upon DRGT reaching certain additional milestones, Mr. Midler has agreed to invest an additional undisclosed amount.

Druggability Technologies Announces Financial Investment by SPCH

San Francisco, CA | Posted on January 14th, 2012

"This investment represents an important validation of the Company's proprietary NanoActive™ technology platform, and provides a stable and solid capital base for the company's anticipated growth over the next few years," said Gabor Heltovics, CEO of DRGT.

"We welcome SPCH to the company and look forward to working with Andrew Midler as we advance the company's business," said Ferenc Darvas, Founder and President of Darholding, DRGT's majority owner.

Andrew Midler, who led this financing said, "We are very pleased with our investment in DRGT, a company we believe will bring to the biopharmaceutical industry transforming new capabilities to enable and improve the delivery of important drugs, and create demonstrable proprietary value in areas of significant unmet need."

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

####

About Druggability Technologies Holdings Ltd
Headquartered in Dublin, Ireland, DRGT, through its subsidiaries, is developing and commercializing its proprietary NanoActive™ high throughput technology platform. This platform delivers improvements in compound solubility, permeability and pharmacokinetics that can be applied across a diverse universe of chemical and biological compounds.

The Company's experience in improving the bioavailability and kinetic profile of drugs is born of a heritage of three decades of scientific and industrial knowledge gained through successful commercial ventures in bio- and chemo-informatics, combinatorial chemistry, chemical genomics, flow chemistry, colloidal chemistry, and nanotechnology.

About SPCH

Standard Pacific Capital Holdings LLLP is an affiliated entity of Savitr Capital LLC, a San Francisco-based investment firm. Savitr combine socially responsible approaches with the goal of providing superior risk adjusted returns.

For more information, please click here

Contacts:
Druggability Technologies Holdings Ltd
Gabor Heltovics
CEO
+36-1-8808-468
+36-1-8808-455 (FAX)

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Caught on camera -- chemical reactions 'filmed' at the single-molecule level March 22nd, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

TriboTEX Uses Nanotechnology to Improve the Efficiency of Old Vehicles March 13th, 2017

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Nanomedicine

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Nanoparticle paves the way for new triple negative breast cancer drug March 20th, 2017

Block copolymer micellization as a protection strategy for DNA origami March 17th, 2017

Announcements

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Argon is not the 'dope' for metallic hydrogen March 24th, 2017

Promising results obtained with a new electrocatalyst that reduces the need for platinum: Researchers from Aalto University have succeeded in manufacturing electrocatalysts used for storing electric energy with one-hundredth of the amount of platinum that is usually needed March 24th, 2017

Artificial photosynthesis steps into the light: Rice University lab turns transition metals into practical catalyst for solar, other applications March 23rd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project